Page last updated: 2024-10-25

cilostazol and Akinetic-Rigid Variant of Huntington Disease

cilostazol has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
El-Abhar, H1
Abd El Fattah, MA1
Wadie, W1
El-Tanbouly, DM1

Other Studies

1 other study available for cilostazol and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
Cilostazol disrupts TLR-4, Akt/GSK-3β/CREB, and IL-6/JAK-2/STAT-3/SOCS-3 crosstalk in a rat model of Huntington's disease.
    PloS one, 2018, Volume: 13, Issue:9

    Topics: Animals; Apoptosis; Cilostazol; Corpus Striatum; CREB-Binding Protein; Cyclic AMP Response Element-B

2018